Review
Published on 26 Feb 2024
Multidisciplinary approach and treatment of acral and mucosal melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1340408
- 1,830 views
- 1 citation
- Frontiers in Oncology
- Skin Cancer
- Articles
Type at least 3 characters
396 articles
Articles
Original Research
Published on 21 Feb 2024
Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center’s decade of experience
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1322116
- 1,503 views
- 2 citations
Review
Published on 08 Feb 2024
Management of acral lentiginous melanoma: current updates and future directions
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1323933
- 3,997 views
- 4 citations
Original Research
Published on 06 Feb 2024
Immunotherapy utilization in stage IIIA melanoma: less may be more
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1336441
- 1,886 views
Case Report
Published on 29 Jan 2024
Case report: Exceptional disease progression in a 70-year-old patient: generalized melanosis and melanuria in the course of metastatic melanoma - a case study
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1332362
- 1,661 views
- 1 citation
Editorial
Published on 17 Jan 2024
Editorial: Non-cutaneous melanoma: new therapeutic insights
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1362238
- 1,568 views
Original Research
Published on 04 Jan 2024
Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1298296
- 2,363 views
- 2 citations
Case Report
Published on 19 Dec 2023
Case report: Parsonage-turner syndrome in a melanoma patient treated by BRAF/MEK inhibitors after immune checkpoint inhibitors
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1268693
- 1,416 views
- 1 citation
Brief Research Report
Published on 19 Dec 2023
Detectable ctDNA at the time of treatment cessation of ipilimumab and nivolumab for toxicity predicts disease progression in advanced melanoma patients
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1280730
- 1,607 views
- 1 citation
Brief Research Report
Published on 04 Dec 2023
Extended long-term follow-up of metastatic melanoma patients treated with immunotherapy: late relapses and second primary melanomas
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1241917
- 5,639 views
Original Research
Published on 30 Nov 2023
Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1256800
- 1,540 views
Case Report
Published on 24 Nov 2023
Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1303141
- 1,819 views
- 2 citations
Original Research
Published on 08 Nov 2023
Cost items in melanoma patients by clinical characteristics and time from diagnosis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1234931
- 1,322 views
- 1 citation
Original Research
Published on 30 Oct 2023
A transcriptional evaluation of the melanoma and squamous cell carcinoma TIL compartment reveals an unexpected spectrum of exhausted and functional T cells
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1200387
- 2,360 views
Case Report
Published on 27 Oct 2023
Covid-19, leukemia, and secondary malignancies of the skin – is there a connection: a case report and literature analysis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1265479
- 3,882 views
Original Research
Published on 25 Oct 2023
Retrospective study of efficacy and adverse events of immune checkpoint inhibitors in 22 xeroderma pigmentosum patients with metastatic or unresectable cancers
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1282823
- 1,751 views